Mi-Geon Jo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mi-Geon Jo has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Chang-Suk Kong
Department of Bioscience, Silla University, Busan 46958, Republic of Korea
1 shared publication - Fang Tan
Department of Bioscience, Silla University, Busan 46958, Republic of Korea
1 shared publication - Jung Hwan Oh
Nutritional Education, Graduate School of Education, Silla University
1 shared publication - Lixuan Ren
Department of Bioscience, Silla University, Busan, Republic of Korea
1 shared publication - Xin Ma
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China
1 shared publication
Latest Publications
- 17 November 2025
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 35 (1) , 229-237
Immunoregulatory effects of Bifidobacterium animalis subsp. animalis QC08 on cyclophosphamide-induced immunosuppression in mice
This study investigated the immunomodulatory effects of Bifidobacterium animalis subsp. animalis QC08 on cyclophosphamide (CTX)-induced immunosuppression in male Kunming mice, randomly divided into five groups: normal, control, positive control (levamisole hydrochloride, 40 mg/kg), low-dose QC08 (2 × 108 CFU/kg), and high-dose QC08 (2 × 1010 CFU/kg). After 21 days of intervention, assessments revealed that both QC08 groups significantly improved body weight, spleen/thymus indices, and histopathological damage in thymus/spleen compared to the model group. Serum pro-inflammatory cytokines (IL-1, TNF-α, IL-6) decreased while anti-inflammatory IL-4 increased. Quantitative real-time PCR of ileal tissue showed upregulated expression of intestinal barrier genes (claudin-1, ZO-1, JAM-A, MUPP1, IKKα, IKKγ) and downregulated inflammatory signaling genes (p50, p52). These results demonstrate that QC08 effectively ameliorates CTX-induced immunosuppression by modulating immune responses and enhancing intestinal barrier integrity, supporting the potential of B. animalis subsp. animalis QC08 for immune-enhancing health food development.
- 17 November 2025
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 35 (1) , 229-237
Immunoregulatory effects of Bifidobacterium animalis subsp. animalis QC08 on cyclophosphamide-induced immunosuppression in mice
This study investigated the immunomodulatory effects of Bifidobacterium animalis subsp. animalis QC08 on cyclophosphamide (CTX)-induced immunosuppression in male Kunming mice, randomly divided into five groups: normal, control, positive control (levamisole hydrochloride, 40 mg/kg), low-dose QC08 (2 × 108 CFU/kg), and high-dose QC08 (2 × 1010 CFU/kg). After 21 days of intervention, assessments revealed that both QC08 groups significantly improved body weight, spleen/thymus indices, and histopathological damage in thymus/spleen compared to the model group. Serum pro-inflammatory cytokines (IL-1, TNF-α, IL-6) decreased while anti-inflammatory IL-4 increased. Quantitative real-time PCR of ileal tissue showed upregulated expression of intestinal barrier genes (claudin-1, ZO-1, JAM-A, MUPP1, IKKα, IKKγ) and downregulated inflammatory signaling genes (p50, p52). These results demonstrate that QC08 effectively ameliorates CTX-induced immunosuppression by modulating immune responses and enhancing intestinal barrier integrity, supporting the potential of B. animalis subsp. animalis QC08 for immune-enhancing health food development.